NEW YORK, August 22, 2022 – Accenture’s Life Sciences Technology Vision 2022 report explores the technology trends that will transform the way biopharmaceutical and medical technology companies solve manufacturing and device problems, improve equity in clinical trial participation and build supply chains. more resilient to provide patients and healthcare professionals with more personalized experiences.
The Metaverse is an evolving and expanding continuum in multiple dimensions – digital and physical – encompassing technologies including augmented reality, blockchain, artificial intelligence, digital twins, immutable tokens and smart devices. According to the report, life sciences executives (91% of medtech executives and 85% of biopharma executives) expect the metaverse to have a positive impact on their organizations, and nearly half of biopharma executives surveyed believe the metaverse will have a breakthrough or transformative impact. on their organizations.
Petra Jantzer, global industry life sciences leader at Accenture, said: “We are in the early days of the metaverse and the technological innovations we implement today – the solutions, products and services that companies offer, how they develop and deliver them, and how they operate at the core of their organizations – they are the building blocks of the future for the life sciences. Industry leaders are creating a new digital future for how people and enterprises interact, and many of the rules remain undefined. It is essential that life sciences companies to take steps to proactively and responsibly shape the metaverse continuum.”
To help life sciences companies design, execute and accelerate their metaverse journeys, Accenture recently launched the Accenture Metaverse Continuum business group, which combines metaverse-savvy professionals and market-leading capabilities in customer experience, digital commerce , augmented reality, blockchain, digital twins. artificial intelligence and computer vision.
The report explores four technological trends that support metaverse continuity:
- WebM illustrates how the Internet is being reimagined with the metaverse as a platform for digital experiences that offer limitless places where people can meet and interact, and Web3 is reinventing how data can be owned by individuals and moved with the person rather than the platform. In the future, a new generation of digital devices will be integrated into the metaverse and may incorporate smart technology into everyday objects such as home appliances and ‘smart’ cars that provide salient data about healthy human behaviors alongside devices. medically regulated as Donisi. can simultaneously detect and analyze multiple bio-parameters.
- The Programmable World traces how technology is moving through our physical environments in three layers: connected, experiential and material. Nearly nine in 10 of the MedTech and biopharma executives surveyed believe that physical environment programming will emerge as a competitive differentiator in their industry. Augmented reality, 5G, ambient computing, 3D printing and smart materials are converging in sophisticated ways, turning the physical world into an environment that is as smart, customizable and as programmable as the digital one.
- The unreal explores the “unreal” qualities that are becoming fundamental to artificial intelligence (AI), even data, making the synthetic seem authentic. Synthetic data is being used to train AI models in ways that real-world data practically cannot or should not. Synthetic data can represent patient datasets for use in research, training, or other applications. These realistic (but unrealistic) data can be partitioned, maintaining the same statistical properties while protecting confidentiality and privacy. It can be developed to accommodate increased diversity to counter bias, thereby overcoming real-world data pitfalls. More than nine-tenths of biopharma (92%) and MedTech (91%) executives report that their organization depends on AI technologies to function effectively.
- Calculating the impossible is the emergence of a new class of machines – quantum computing – that stretches the limits of what computers can do. Problems that were once considered impossible to solve because they require computation of large, complex data are now in the realm of the possible. Almost all surveyed biopharma (94%) and MedTech (96%) executives agree that their organization is pivoting in response to the unprecedented computing power that is becoming available.
The Life Sciences Technology Vision 2022 report can be accessed here.
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized capabilities in more than 40 industries, we offer Strategy & Consulting, Technology & Operations, and Accenture Song services — all powered by the world’s largest network of advanced technology centers and intelligent operations. Our 710,000 people deliver on the promise of technology and human ingenuity every day, serving customers in more than 120 countries. We embrace the power of change to create value and shared success for our customers, people, shareholders, partners and communities.